← peptides typeshit

Sekhar says to follow CDMO capex, not modality buzz like peptides and ADCs

An investor take on Indian contract manufacturers: the argument is that spending on plants for peptides, ADCs and oligos matters more than concall buzz.

See it on X

Recap by typeshit. Post by Sekhar on X.